EASL 2009: Boceprevir Achieves Highest Cure Rate Ever Against Hepatitis C in SPRINT-1
EASL 2009: Boceprevir Achieves Highest Cure Rate Ever Against Hepatitis C in SPRINT-1
May 4th, 2009 by Rahil ShahThis trial looks promising
No comments yet.
Sign In to leave a comment.